Clinical Trial Update: Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting completion of intravitreal bevacizumab for proliferative diabetic retinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy
• Vitreous Hemorrhage

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Khon Kaen University | Conditions: Vitreous Hemorrhage, Proliferative Diabetic Retinopathy | Phase 4 | Status: COMPLETED